| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| The Johns Hopkins Ovarian Cancer Center of Excellence acknowledges and thanks Aventis, Genzyme, GlaxoSmithKline, Oncotech, Ortho Biotech, and The Pam McDonald Fund for their support of this website through provision of unrestricted educational grants. |
|
 |
|
 |
|
The Statistics...
- Ovarian cancer is the second most common gynecologic cancer after uterine cancer.
- It causes more deaths than any other gynecologic cancer.
- Ovarian cancer is the fourth leading cause of cancer death among women in the United States.
- In 2007, The American Cancer Society estimates 21,650 women in the U.S. who are diagnosed with ovarian cancer, with 15,520 of those women dying from this disease.
- The risk of ovarian cancer increases with age, and family history of the disease is one of the most significant risk factors.
- Close to 80 percent of ovarian cancer patients recently diagnosed with the disease will survive one year and about half will survive five years. Almost all women with local disease will survive five years, but fewer than 30 percent at this stage.
Source: American Cancer Society, Surveillance Research, 2007. |
|
